CBD And CBG Show Promising Results In Treating Glioblastoma Brain Tumors
MGC Pharmaceuticals (LON: MXC), a publicly-traded cannabis company, recently finalized pre-clinical trial research of cannabinoids as a potential treatment for glioblastoma, an aggressive brain cancer. The results were positive,
